Jeffrey Robert Ajer - 29 Mar 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
29 Mar 2022
Net transactions value
-$238,390
Form type
4
Filing time
31 Mar 2022, 21:28:18 UTC
Previous filing
24 Mar 2022
Next filing
14 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale $128,518 -1,618 -2.7% $79.43 57,638 29 Mar 2022 Direct F1
transaction BMRN Common Stock Sale $109,872 -1,381 -2.4% $79.56 56,257 30 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on February 28, 2022.